Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts.
Chernyshov PV, Tomas-Aragones L, Manolache L, Pustisek N, Salavastru CM, Marron SE, Bewley A, Svensson A, Poot F, Suru A, Salek SS, Augustin M, Szepietowski JС, Koumaki D, Katoulis AC, Sampogna F, Abeni D, Linder DM, Speeckaert R, van Geel N, Seneschal J, Ezzedine K, Finlay AY. Chernyshov PV, et al. Among authors: speeckaert r. J Eur Acad Dermatol Venereol. 2023 Jan;37(1):21-31. doi: 10.1111/jdv.18593. Epub 2022 Oct 19. J Eur Acad Dermatol Venereol. 2023. PMID: 36259656
Koebner's phenomenon in vitiligo: European position paper.
van Geel N, Speeckaert R, Taieb A, Picardo M, Böhm M, Gawkrodger DJ, Schallreuter K, Bennett DC, van der Veen W, Whitton M, Moretti S, Westerhof W, Ezzedine K, Gauthier Y; VETF members. van Geel N, et al. Among authors: speeckaert r. Pigment Cell Melanoma Res. 2011 Jun;24(3):564-73. doi: 10.1111/j.1755-148X.2011.00838.x. Epub 2011 Mar 7. Pigment Cell Melanoma Res. 2011. PMID: 21324101 Review.
Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis.
van Geel N, Speeckaert R, Lambert J, Mollet I, De Keyser S, De Schepper S, Brochez L. van Geel N, et al. Among authors: speeckaert r. J Eur Acad Dermatol Venereol. 2012 Jun;26(6):755-61. doi: 10.1111/j.1468-3083.2011.04160.x. Epub 2011 Jun 23. J Eur Acad Dermatol Venereol. 2012. PMID: 21696452
New insights in segmental vitiligo: case report and review of theories.
van Geel N, Mollet I, Brochez L, Dutré M, De Schepper S, Verhaeghe E, Lambert J, Speeckaert R. van Geel N, et al. Among authors: speeckaert r. Br J Dermatol. 2012 Feb;166(2):240-6. doi: 10.1111/j.1365-2133.2011.10650.x. Epub 2011 Dec 14. Br J Dermatol. 2012. PMID: 21936857 Review.
In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial.
van Geel N, Speeckaert R, Mollet I, De Schepper S, De Wolf J, Tjin EP, Luiten RM, Lambert J, Brochez L. van Geel N, et al. Among authors: speeckaert r. Pigment Cell Melanoma Res. 2012 Jan;25(1):57-65. doi: 10.1111/j.1755-148X.2011.00922.x. Epub 2011 Nov 2. Pigment Cell Melanoma Res. 2012. PMID: 21982055 Clinical Trial.
The distribution pattern of segmental vitiligo: clues for somatic mosaicism.
van Geel N, Speeckaert R, Melsens E, Toelle SP, Speeckaert M, De Schepper S, Lambert J, Brochez L. van Geel N, et al. Among authors: speeckaert r, speeckaert m. Br J Dermatol. 2013 Jan;168(1):56-64. doi: 10.1111/bjd.12013. Epub 2012 Dec 13. Br J Dermatol. 2013. PMID: 22913564
Clinical significance of Koebner phenomenon in vitiligo.
van Geel N, Speeckaert R, De Wolf J, Bracke S, Chevolet I, Brochez L, Lambert J. van Geel N, et al. Among authors: speeckaert r. Br J Dermatol. 2012 Nov;167(5):1017-24. doi: 10.1111/j.1365-2133.2012.11158.x. Epub 2012 Sep 5. Br J Dermatol. 2012. PMID: 22950415
148 results